Find below a collection of articles and guidelines we constantly research to share the most up to date information about ocular melanoma in Canada and around the world.
For questions or feedback Contact us at ocumelcanada@saveyourskin.ca or 1-800-460-5832
Uveal Melanoma, Prognostic Genetic Test – about ocular melanoma and available testing in Canada
NCCN Clinical Practice Guidelines®: Uveal Melanoma v 1.2018 – March 15, 2018
OM Guidelines for Management – Scanning frequency recommended by Thomas Jefferson Hospital, Philadelphia, U.S.
Management of uveal melanoma: a consensus-based provincial clinical practice guideline – Current Oncology: Alberta, Canada, February 18, 2016
ThinkUvealMelanoma.com – Resources for health care providers, by Immunocore
- 2021 Ocumel Canada Activity Report
- Ocumel Canada Patient Survey Report – Updating the OM Care Landscape in Canada, 2021
- Our 2018-2020 activity and work across Canada
Youtube Playlist: Meet Ocumel Canada – Including presentations by Dr. Butler @ PMH, and Dr. Burnier @ McGill
Learn more about our joint initiatives with CureOM (an initiative of Melanoma Research Foundation, U.S.), Ocumel UK, Ocumel Ireland, and AOMA in Australia. Together we share global best practices and research emerging from all over so that we can get this information to Canadian patients and caregivers touched by OM.
In November 2020 we joined these groups for the 9th Annual Eyes on a Cure: Ocular Melanoma Patient and Caregiver Symposium. CureOM, in partnership with Ocumel Canada, OcuMel UK, Ocumel Ireland and the Australasian Ocular Melanoma Alliance we were able to bring over 50 sessions from across the globe that included adjuvant therapy, COVID-19 and OM, clinical trials, OM research updates, accepting your new normal, scanxiety, a registry update and more.
CureOM 2020 Symposium Playlist – Click HERE to view the recordings
Thank you to CureOM for inviting OcuMel UK, Ocumel Ireland and Ocumel Canada to take part in the first-ever international panel discussion at the 2019 CureOM Eyes on a Cure: Patient & Caregiver Symposium! We’re honoured to have such dedicated partners and excited for what’s to come. April 2019, Raleigh, NC, U.S.
Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma, April 2022
Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma, November 2021
Nature Reviews Disease Primers – Uveal Melanoma, April 9, 2020
Shift in treatment modalities associated with improved outcomes in uveal melanoma patients with liver metastasis, Thomas Jefferson University, 3-Feb-2
Presentation to Patients, by Dr. Damato: Improving the care pathway for patients with ocular melanoma
CureToday.com – Advances and Combinations Raise Sights on Uveal Melanoma
Blog for #EyeGetDilated campaign – #EyeGetDilated: Be Smart. Beat it. – CureOM, Melanoma Research Foundation
UpToDate.com – Management of Metastatic Uveal Melanoma, by Dr. R. Carvajal
Current Oncology: Management of uveal melanoma: a consensus-based provincial clinical practice guideline – Alberta, Canada, February 18, 2016
Ocular oncologist and research lab join forces to save patient with eye cancer – McGill University Health Centre
Vision Health Research Network, Quebec
Webinar: Ocular Melanoma
February-2019
With Dr. Marcus Butler, Princess Margaret Cancer Centre, Toronto, Canada & Dr. Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, California
Listed above are a few sources of information and support you might find useful. These groups are not connected to Save Your Skin Foundation. We are providing the links as useful sources of information but do not monitor content for accuracy and quality.
NOTE: The information on the Save Your Skin Foundation website is not intended to replace the medical advice of a doctor or healthcare provider. While we make every effort to ensure that the information on our site is as current as possible, please note that information and statistics are subject to change as new research and studies are published.
Making awareness and education available is crucial. Since 2006, the Foundation has worked to raise awareness of melanoma and non-melanoma skin cancers, and ocular melanoma, focusing on the need for improved patient care.
